Temocapril is a dipeptide. Temocapril is a prodrug-type angiotensin-I converting enzyme (ACE) inhibitor not approved for use in the United States, but is approved in Japan and South Korea. Temocapril can also be used in hemodialysis patients without risk of serious accumulation. It is grouped under the following drug class(es): ACE Inhibitors. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Temocaprilum, 2-[(2S)-6-[[(1S)-1-Ethoxycarbonyl-3-phenyl-propyl]amino]-5-oxo-2-thiophen-2-yl-1 and 4-thiazepan-4-yl]acetic acid. Its PubChem CID is 443874.
Temocapril
| CAS No | 111902-57-9 |
|---|---|
| Molecular Formula | C23H28N2O5S2 |
| Molecular Weight | 476.6 g/mol |
| Synonyms | 2-[(2S,6R)-6-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-5-oxo-2-thiophen-2-yl-1,4-thiazepan-4-yl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Temocapril is a dipeptide. Temocapril is a prodrug-type angiotensin-I converting enzyme (ACE) inhibitor not approved for use in the United States, but is approved in Japan and South Korea.
The listed CAS number is 111902-57-9.
The listed molecular formula is C23H28N2O5S2.
The listed molecular weight is 476.6 g/mol.
2-[(2S,6R)-6-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-5-oxo-2-thiophen-2-yl-1,4-thiazepan-4-yl]acetic acid.
The source lists Temocaprilum, 2-[(2S)-6-[[(1S)-1-Ethoxycarbonyl-3-phenyl-propyl]amino]-5-oxo-2-thiophen-2-yl-1 and 4-thiazepan-4-yl]acetic acid.